{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:27:36Z","timestamp":1789586856824,"version":"build-2803163510"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2021,5,7]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>A recent survey reported an association between fibromyalgia and overactive bladder.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective::<\/jats:title>\n<jats:p>To carry out the first systematic case-controlled study to compare the level of overactive bladder symptoms in a group of fibromyalgia patients and a group of matched controls.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods::<\/jats:title>\n<jats:p>The symptom-bother OAB-q8 questionnaire and Revised Fibromyalgia Impact Questionnaire (FIQR) were administered to 27 patients who fulfilled the revised diagnostic criteria for fibromyalgia of the American College of Rheumatology and to 26 healthy controls who had no history of suffering from fibromyalgia or any other rheumatological or neurological illness.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>The groups were matched in respect of age, sex and ethnicity. None of the 53 subjects was taking medication which might cause urinary urgency, none was suffering from, or had recently suffered from, a urinary tract infection and none had undergone a previous operative procedure on the lower urinary tract. Twenty-five (93%) patients had evidence of an overactive bladder during the previous four weeks, compared with five (19%) of the control group (p &lt; 0.001). In terms of symptom severity, the mean (standard error) OAB-q8 score was 24.4 (1.5) in the fibromyalgia patients and 10.8 (4.5) in the controls (p &lt; 0.001). Furthermore, the total OAB-q8 and FIQR scores were positively correlated (rs = 0.727, p &lt; 0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>This systematic controlled study confirms that fibromyalgia is associated with overactive bladder symptoms. The relatively high prevalence of 93% indicates that overactive bladder is an important urological association of fibromyalgia and should be routinely assessed in these patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574887115999201006201328","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T05:50:22Z","timestamp":1602049822000},"page":"202-205","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Overactive Bladder Symptoms in Patients with Fibromyalgia: A Systematic Case-Controlled Study"],"prefix":"10.2174","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6101-0139","authenticated-orcid":true,"given":"Basant K.","family":"Puri","sequence":"first","affiliation":[{"name":"C.A.R., Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8521-6534","authenticated-orcid":true,"given":"Gary S.","family":"Lee","sequence":"additional","affiliation":[{"name":"University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"Haylen B.T.","year":"2010","unstructured":"Haylen B.T.; de Ridder D.; Freeman R.M.; Swift S.E.; Berghmans B.; Lee J.; Monga A.; Petri E.; Rizk D.E.; Sand P.K.; Schaer G.N.; An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010,29(1),4-20","journal-title":"Neurourol Urodyn"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"Abrams P.","year":"2003","unstructured":"Abrams P.; Cardozo L.; Fall M.; Griffiths D.; Rosier P.; Ulmsten U.; Van Kerrebroeck P.; Victor A.; Wein A.; The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology 2003,61(1),37-49","journal-title":"Urology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00345-011-0742-8","volume":"30","author":"Abrams P.","year":"2012","unstructured":"Abrams P.; Chapple C.R.; J\u00fcnemann K-P.; Sharpe S.; Urinary urgency: A review of its assessment as the key symptom of the overactive bladder syndrome. World J Urol 2012,30(3),385-392","journal-title":"World J Urol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5213\/inj.1832554.277","volume":"22","author":"Chuang F-C.","year":"2018","unstructured":"Chuang F-C.; Hsiao S-M.; Kuo H-C.; The Overactive Bladder Symptom Score, International Prostate Symptom Score\u2013Storage subscore, and Urgency Severity Score in patients with overactive bladder and hypersensitive bladder: Which scoring system is best? Int Neurourol J 2018,22(2),99-106","journal-title":"Int Neurourol J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"Clauw D.J.","year":"2014","unstructured":"Clauw D.J.; Fibromyalgia: A clinical review. JAMA 2014,311(15),1547-1555","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1573397111666150619095007","volume":"11","author":"Boomershine C.S.","year":"2015","unstructured":"Boomershine C.S.; Fibromyalgia: The prototypical central sensitivity syndrome. Curr Rheumatol Rev 2015,11(2),131-145","journal-title":"Curr Rheumatol Rev"},{"key":"ref=7","first-page":"6","volume":"35","author":"Talotta R.","year":"2017","unstructured":"Talotta R.; Bazzichi L.; Di Franco M.; Casale R.; Batticciotto A.; Gerardi M.C.; Sarzi-Puttini P.; One year in review 2017: Fibromyalgia. Clin Exp Rheumatol 2017,35(3)(Suppl. 105),6-12","journal-title":"Clin Exp Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.autneu.2013.12.005","volume":"182","author":"Birder L.A.","year":"2014","unstructured":"Birder L.A.; Urinary bladder, cystitis and nerve\/urothelial interactions. Auton Neurosci 2014,182,89-94","journal-title":"Auton Neurosci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00192-019-04011-x","volume":"30","author":"Matthews C.A.","year":"2019","unstructured":"Matthews C.A.; Deveshwar S.P.; Evans R.J.; Badlani G.; Walker S.J.; Small fiber polyneuropathy as a potential therapeutic target in interstitial cystitis\/bladder pain syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2019,30(11),1817-1820","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/iju.12379","volume":"21","author":"Cervigni M.","year":"2014","unstructured":"Cervigni M.; Natale F.; Gynecological disorders in bladder pain syndrome\/interstitial cystitis patients. Int J Urol 2014,21(Suppl. 1),85-88","journal-title":"Int J Urol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/nau.22277","volume":"32","author":"Chung J.H.","year":"2013","unstructured":"Chung J.H.; Kim S.A.; Choi B.Y.; Lee H-S.; Lee S.W.; Kim Y.T.; Lee T.Y.; Moon H.S.; The association between overactive bladder and fibromyalgia syndrome: A community survey. Neurourol Urodyn 2013,32(1),66-69","journal-title":"Neurourol Urodyn"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"Wolfe F.","year":"2010","unstructured":"Wolfe F.; Clauw D.J.; Fitzcharles M-A.; Goldenberg D.L.; Katz R.S.; Mease P.; Russell A.S.; Russell I.J.; Winfield J.B.; Yunus M.B.; The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010,62(5),600-610","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"Wolfe F.","year":"1990","unstructured":"Wolfe F.; Smythe H.A.; Yunus M.B.; Bennett R.M.; Bombardier C.; Goldenberg D.L.; Tugwell P.; Campbell S.M.; Abeles M.; Clark P.; The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990,33(2),160-172","journal-title":"Arthritis Rheum"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"Wolfe F.","year":"2016","unstructured":"Wolfe F.; Clauw D.J.; Fitzcharles M-A.; Goldenberg D.L.; H\u00e4user W.; Katz R.L.; Mease P.J.; Russell A.S.; Russell I.J.; Walitt B.; 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016,46(3),319-329","journal-title":"Semin Arthritis Rheum"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/A:1016370925601","volume":"11","author":"Coyne K.","year":"2002","unstructured":"Coyne K.; Revicki D.; Hunt T.; Corey R.; Stewart W.; Bentkover J.; Kurth H.; Abrams P.; Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q. Qual Life Res 2002,11(6),563-574","journal-title":"Qual Life Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"Bennett R.M.","year":"2009","unstructured":"Bennett R.M.; Friend R.; Jones K.D.; Ward R.; Han B.K.; Ross R.L.; The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. Arthritis Res Ther 2009,11(4),R120","journal-title":"Arthritis Res Ther"},{"key":"ref=17","year":"2017","unstructured":"R: A Language and Environment for Statistical Computing  Vienna, Austria: R Foundation for Statistical Computing 2017","journal-title":"R: A Language and Environment for Statistical Computing  Vienna, Austria: R Foundation for Statistical Computing"},{"key":"ref=18","year":"2020","unstructured":"JASP (Version 013) University of Amsterdam JASP Team2020","journal-title":"JASP (Version 013) University of Amsterdam"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1442-2042.2012.02966.x","volume":"19","author":"Furuta A.","year":"2012","unstructured":"Furuta A.; Suzuki Y.; Hayashi N.; Egawa S.; Yoshimura N.; Transient receptor potential A1 receptor-mediated neural cross-talk and afferent sensitization induced by oxidative stress: Implication for the pathogenesis of interstitial cystitis\/bladder pain syndrome. Int J Urol 2012,19(5),429-436","journal-title":"Int J Urol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11011-019-0388-6","volume":"34","author":"Morris G.","year":"2019","unstructured":"Morris G.; Maes M.; Berk M.; Puri B.K.; Myalgic encephalomyelitis or chronic fatigue syndrome: How could the illness develop? Metab Brain Dis 2019,34(2),385-415","journal-title":"Metab Brain Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1007\/s12035-018-0928-9","volume":"55","author":"Monro J.A.","year":"2018","unstructured":"Monro J.A.; Puri B.K.; A molecular neurobiological approach to understanding the aetiology of chronic fatigue syndrome (myalgic encephalomyelitis or systemic exertion intolerance disease) with treatment implications. Mol Neurobiol 2018,55(9),7377-7388","journal-title":"Mol Neurobiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mehy.2017.12.006","volume":"110","author":"Hulens M.","year":"2018","unstructured":"Hulens M.; Dankaerts W.; Stalmans I.; Somers A.; Vansant G.; Rasschaert R.; Bruyninckx F.; Fibromyalgia and unexplained widespread pain: The idiopathic cerebrospinal pressure dysregulation hypothesis. Med Hypotheses 2018,110,150-154","journal-title":"Med Hypotheses"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.2147\/JPR.S186878","volume":"11","author":"Hulens M.","year":"2018","unstructured":"Hulens M.; Rasschaert R.; Vansant G.; Stalmans I.; Bruyninckx F.; Dankaerts W.; The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: Exploration of a shared pathophysiology. J Pain Res 2018,11,3129-3140","journal-title":"J Pain Res"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203755","volume":"13","author":"Wolfe F.","year":"2018","unstructured":"Wolfe F.; Walitt B.; Perrot S.; Rasker J.J.; H\u00e4user W.; Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS One 2018,13(9)","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.oooo.2019.02.023","volume":"128","author":"Ayouni I.","year":"2019","unstructured":"Ayouni I.; Chebbi R.; Hela Z.; Dhidah M.; Comorbidity between fibromyalgia and temporomandibular disorders: A systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2019,128(1),33-42","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/key112","volume":"57","author":"Duffield S.J.","year":"2018","unstructured":"Duffield S.J.; Miller N.; Zhao S.; Goodson N.J.; Concomitant fibromyalgia complicating chronic inflammatory arthritis: A systematic review and meta-analysis. Rheumatology (Oxford) 2018,57(8),1453-1460","journal-title":"Rheumatology (Oxford)"}],"container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/186687","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186687\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/186687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T19:18:16Z","timestamp":1634411896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186687\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574887115999201006201328","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}